Bronnen: wij volgen de wijzigingen op basis van informatie van het College ter Beoordeling van Geneesmiddelen (CBG) — de Geneesmiddeleninformatiebank (inschrijvingen en doorgehaalde handelsvergunningen, dagelijks vergeleken) en DHPC-brieven — en van de Inspectie Gezondheidszorg en Jeugd (terugroepacties). Besluiten over centraal toegelaten geneesmiddelen komen uit het Uniebestand van de Europese Commissie (EU-label). Voor tekorten en vergoedingen bestaan in Nederland geen open overheidsgegevens; die staan hier (nog) niet. Alternatieven met dezelfde werkzame stof: database van Lekoskop.
nr. EU/1/26/2074 · FREHEMGO is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia A (congenital … · Novo Nordisk A/S · denecimig
nr. EU/1/24/1849 · toegelaten op 22-08-2024 · mRESVIA is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caus… · MODERNA BIOTECH SPAIN, S.L. · Single-stranded 5' capped mRNA encoding the respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation · ATC J07BX05
nr. EU/1/17/1250 · toegelaten op 24-05-2018 · Rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (FIGO Stages… · pharmaand GmbH · rucaparib · ATC L01XK03
nr. EU/1/07/391 · toegelaten op 14-06-2007 · Multiple myeloma
Revlimid as monotherapy is indicated for the maintenance treatment of adult patients with ne… · Bristol-Myers Squibb Pharma EEIG · Lenalidomide · ATC L04AX04
nr. EU/1/16/1089 · toegelaten op 20-05-2016 · Pandemic influenza vaccine H5N1 AstraZeneca is indicated for active immunisation against influenza in an offic… · AstraZeneca AB · Pandemic influenza vaccine (H5N1) (live, nasal) · ATC J07BB03
nr. EU/1/07/389 · toegelaten op 21-05-2007 · Rheumatoid arthritis
ORENCIA, in combination with methotrexate, is indicated for:
- the treatment of moder… · Bristol-Myers Squibb Pharma EEIG · abatacept · ATC L04AA24
nr. EU/1/21/1617 · toegelaten op 14-02-2022 · Ngenla is indicated for the treatment of children and adolescents from 3 years of age with growth disturbance … · Pfizer Europe MA EEIG · somatrogon · ATC H01AC08
nr. EU/1/24/1862 · toegelaten op 25-09-2024 · Plaque psoriasis
Fymskina is indicated for the treatment of moderate to severe plaque psoriasis in adults who… · Formycon AG · ustekinumab · ATC L04AC05
nr. EU/1/24/1883 · toegelaten op 13-01-2025 · AUGTYRO as monotherapy is indicated for the treatment of adult patients with ROS1-positive advanced non-small … · Bristol Myers Squibb Pharma EEIG · repotrectinib · ATC L01EX28
nr. EU/1/20/1506 · toegelaten op 05-02-2021 · Kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and abo… · Biosimilar Collaborations Ireland Limited · Insulin aspart · ATC A10AB05
nr. EU/1/23/1764 · toegelaten op 01-12-2023 · Zilbrysq is indicated as an add-on to standard therapy for the treatment of generalised myasthenia gravis (gMG… · UCB Pharma S.A. · zilucoplan · ATC L04AJ06
nr. EU/1/22/1696 · toegelaten op 09-11-2022 · Hepatocellular carcinoma
Sorafenib Accord is indicated for the treatment of hepatocellular carcinoma.
Rena… · Accord Healthcare S.L.U. · sorafenib · ATC L01EX02
nr. EU/1/18/1318 · toegelaten op 20-09-2018 · Slenyto is indicated for:
- treatment of insomnia in children and adolescents aged 2-18 years with Autism Spe… · RAD Neurim Pharmaceuticals EEC SARL · melatonin · ATC N05CH01
nr. EU/1/25/1958 · toegelaten op 17-07-2025 · Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal… · Sandoz GmbH · denosumab · ATC M05BX04
nr. EU/1/16/1137 · toegelaten op 14-11-2016 · Adults
Treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II… · Accord Healthcare S.L.U. · sildenafil · ATC G04BE03
nr. EU/1/24/1884 · toegelaten op 13-01-2025 · Gohibic is indicated for the treatment of adult patients with SARS CoV2 induced acute respiratory distress syn… · InflaRx GmbH · vilobelimab · ATC L04AJ10
nr. EU/1/20/1454 · toegelaten op 19-08-2020 · Aybintio in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients … · Samsung Bioepis NL B.V. · bevacizumab · ATC L01FG01
nr. EU/1/20/1501 · toegelaten op 31-03-2021 · Paediatric patients
Sogroya is indicated for treatment of growth failure in children and adolescents in the… · Novo Nordisk A/S · somapacitan · ATC H01AC07
nr. EU/1/20/1480 · toegelaten op 24-09-2020 · Rheumatoid arthritis:
Jyseleca is indicated for the treatment of moderate to severe active rheumatoid arthrit… · Alfasigma S.p.A. · filgotinib · ATC L04AF04
nr. EU/1/24/1905 · toegelaten op 14-02-2025 · Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal… · Celltrion Healthcare Hungary Kft. · Denosumab · ATC M05BX04
nr. EU/1/23/1744 · toegelaten op 05-01-2024 · Krazati as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung canc… · Bristol Myers Squibb Pharma EEIG · adagrasib · ATC L01XX77
nr. EU/1/20/1439 · toegelaten op 30-05-2020 · Atectura Breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of ag… · Novartis Europharm Limited · indacaterol / mometasone furoate · ATC R03AK14